![Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | SpringerLink Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12026-012-8268-8/MediaObjects/12026_2012_8268_Fig1_HTML.gif)
Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | SpringerLink
![Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection | Science Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection | Science](https://www.science.org/cms/10.1126/science.aaf8505/asset/9f11bfb5-c695-48e1-82be-141a8bb68957/assets/graphic/353_823_f1.jpeg)
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection | Science
![Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121001567-fx1.jpg)
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect
![The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00809-x/MediaObjects/41577_2022_809_Fig1_HTML.png)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
![A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/bf57f49f-ebd3-4ce0-8bc0-bbf88947b5be/emmm202215821-abs-0001-m.jpg)
A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine
Evaluation of Allergic Cross-Reactivity Among Fishes by Microfluidic Chips and MALDI-TOF MS | Journal of Agricultural and Food Chemistry
![Significant cross reactive antibodies to influenza virus in adults and children during a period of marked antigenic drift | BMC Infectious Diseases | Full Text Significant cross reactive antibodies to influenza virus in adults and children during a period of marked antigenic drift | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2334-14-346/MediaObjects/12879_2014_Article_3677_Fig3_HTML.jpg)
Significant cross reactive antibodies to influenza virus in adults and children during a period of marked antigenic drift | BMC Infectious Diseases | Full Text
![Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/03/18/2020.03.17.995738/F1.large.jpg)
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
![Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K. Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K.](https://journals.sagepub.com/cms/10.1177/0192623310382559/asset/images/large/10.1177_0192623310382559-fig3.jpeg)